FDA Adverse Event Other Summary report: N

VARIS VISION TREATMENT EVI

MDR report key: 747450 · Received October 31, 2005

Report

Report Number
2914292-2005-00008
Event Type
Other
Date Received
October 31, 2005
Date of Event
May 26, 2005
Report Date
October 30, 2005
Manufacturer
VARIAN MEDICAL SYSTEMS
Product Code
IYE
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
INVALID DATA

Narratives

Additional Manufacturer Narrative · 1

DURING THE INVESTIGATION PERFORMED BY VARIAN IT WAS DISCOVERED THAT IF A SYMMETRIC FIELD IS MODED UP WHEN THE LINAC ACTUAL POSITIONS ARE ASYMMETRIC, AND THE LINAC X1 OR Y1 JAW VALUE IS 1/2 OF THE PLAN SYMMETRIC VALUE, THEN THE X2 OR Y2 JAW VALUE CAN BE OUT OF POSITION AND VARIS VISION WILL NOT INHIBIT TREATMENT. IF THE OPERATOR OVERLOOKS THE FIELD SIZE DISCREPANCY, THE PT COULD BE TREATED WITH THE WRONG FIELD. UPON INITIAL REVIEW OF THIS ISSUE ON JUNE 14TH, 2005, THE HAZARD ANALYSIS TEAM INDICATED THAT A SERIOUS INJURY WAS NOT LIKELY. HOWEVER, UPON FURTHER REVIEW ON JUNE 21, 2005, IT WAS DETERMINED THAT THIS ISSUE COULD LIKELY RESULT IN A SERIOUS INJURY TO A CRITICAL STRUCTURE IF IT WERE TO RECCUR. A PRODUCT NOTIFICATION LETTER WAS DISTRIBUTED ON SEPTEMBER 20, 2005 TO ALL RELEVANT CUSTOMERS WARNING THEM OF THIS ISSUE. A CORRECTION NOTICE WAS SENT TO THE LOCAL RECALL COORDINATOR ON OCTOBER 4, 2005. A FIX FOR THIS PROBLEM HAS BEEN CREATED AND WILL BE APPLIED TO THE CUSTOMER SYSTEMS.

Description of Event or Problem · 1

A CUSTOMER REPORTED THE FOLLOWING EVENT: THE PLANNED FIELD SIZE WAS 20X20. THE Y ACTUAL VALUE WAS 20, BUT THE X ACTUAL WAS 11. VARIS DID NOT SHOW AN ORANGE BOX ON THE X SIZE TO SHOW IT WAS OUT OF TOLERANCE. THE "RADIOGS" USED ASU AND THE LINAC WENT TO THE PLANNED POSITION. THE CUSTOMER NOTICED THE DISCREPANCY, THEREFORE THERE WAS NOT A MISTREATMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VARIS VISION TREATMENT EVI ACCELERATOR, LINEAR, MEDICAL-SOFTWARE IYE VARIAN MEDICAL SYSTEMS NA NA

Patients

Seq Age Sex Outcome Treatment
1 Other